PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11550089-0	2001	Extended polyglutamine selectively interacts with caspase-8 and -10 in nuclear aggregates.	polyglutamine	9-22	caspase 8	Homo sapiens	50-67	
11550089-3	2001	We and others previously demonstrated that caspase-8 was activated by proteolysis in association with the expression of extended polyglutamine.	polyglutamine	129-142	caspase 8	Homo sapiens	43-52	
11550089-6	2001	Caspase-8 and -10 were recruited into nuclear aggregates of extended polyglutamine, where at least a fraction of these caspases was converted to the activated forms.	polyglutamine	69-82	caspase 8	Homo sapiens	0-17	
11550089-7	2001	Caspase-8 and -10 were co-immunoprecipitated with polyglutamine only when the polyglutamine was pathologically extended, whereas caspase-2, -3, -6, -7 and -9 were not co-immunoprecipitated with polyglutamine regardless of its size.	polyglutamine	50-63	caspase 8	Homo sapiens	0-17	
11550089-7	2001	Caspase-8 and -10 were co-immunoprecipitated with polyglutamine only when the polyglutamine was pathologically extended, whereas caspase-2, -3, -6, -7 and -9 were not co-immunoprecipitated with polyglutamine regardless of its size.	polyglutamine	78-91	caspase 8	Homo sapiens	0-17	
11550089-7	2001	Caspase-8 and -10 were co-immunoprecipitated with polyglutamine only when the polyglutamine was pathologically extended, whereas caspase-2, -3, -6, -7 and -9 were not co-immunoprecipitated with polyglutamine regardless of its size.	polyglutamine	78-91	caspase 8	Homo sapiens	0-17	
11550089-8	2001	A dominant-negative form of caspase-8 with a mutation at the catalytic cysteine residue inhibited polyglutamine-mediated nuclear apoptotic phenotype.	polyglutamine	98-111	caspase 8	Homo sapiens	28-37